FERRARI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.293
EU - Europa 811
AS - Asia 369
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.548
Nazione #
US - Stati Uniti d'America 1.292
GB - Regno Unito 259
CN - Cina 153
SG - Singapore 145
IT - Italia 129
DE - Germania 116
SE - Svezia 113
IE - Irlanda 47
IN - India 46
RU - Federazione Russa 39
FR - Francia 31
CI - Costa d'Avorio 26
ZA - Sudafrica 26
EE - Estonia 25
TG - Togo 20
CH - Svizzera 15
UA - Ucraina 14
VN - Vietnam 14
BE - Belgio 8
JO - Giordania 8
BG - Bulgaria 3
NL - Olanda 3
ES - Italia 2
EU - Europa 2
FI - Finlandia 2
PL - Polonia 2
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
LB - Libano 1
MU - Mauritius 1
Totale 2.548
Città #
Southend 246
Fairfield 168
Chandler 156
Singapore 129
Ashburn 108
Woodbridge 96
Wilmington 77
Santa Clara 75
Houston 68
Seattle 59
Ann Arbor 55
Princeton 52
Dublin 47
Boardman 44
Cambridge 41
Nanjing 27
Padova 27
Abidjan 26
Westminster 25
Turin 23
Bremen 21
Dearborn 21
Bologna 20
Lomé 20
Medford 15
Saint Petersburg 15
Bern 14
Nanchang 13
Beijing 12
San Diego 12
Falls Church 11
Berlin 9
Jinan 9
Los Angeles 9
Amman 8
Brussels 8
Changsha 8
Hangzhou 8
Hebei 8
Catanzaro 6
Shenyang 6
Redwood City 5
Haikou 4
Jiaxing 4
Milan 4
Ningbo 4
Taizhou 4
Zhengzhou 4
Frattamaggiore 3
Guangzhou 3
Harbin 3
Moscow 3
Sofia 3
Tianjin 3
Wuppertal 3
Barcelona 2
Barletta 2
Bühl 2
Den Haag 2
Francavilla Al Mare 2
Frankfurt Am Main 2
Helsinki 2
Kilburn 2
Lanzhou 2
Naples 2
Napoli 2
Redmond 2
Wuhan 2
Amsterdam 1
Bari 1
Brescia 1
Chengdu 1
Dhaka 1
Duncan 1
Falkenstein 1
Fontenay-sous-bois 1
Galatina 1
Hanoi 1
Hefei 1
Hialeah 1
Landshut 1
Las Vegas 1
Linyi 1
Montereale 1
Mountain View 1
New Rochelle 1
Nichelino 1
Norwalk 1
Olalla 1
Olgiate Molgora 1
Omaha 1
Orange 1
Phoenix 1
Pingdingshan 1
Quispamsis 1
Riva 1
Rome 1
Serra 1
Shanghai 1
Shenzhen 1
Totale 1.910
Nome #
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 132
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 129
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 126
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 118
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 112
Emerging therapeutic targets for synovial sarcoma 110
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 109
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 107
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 103
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 102
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 101
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 100
Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy. 96
Imaging in bone sarcomas. the chemotherapist's point of view 94
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 93
null 92
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 90
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 90
Periosteal osteosarcoma: a single-institution experience. 90
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study. 87
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 86
A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian sarcoma group (ISG) study. 85
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 85
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 84
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 80
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 56
MRgFUS new applications in musculoskeletal pathology: a miscellaneous case review 44
Totale 2.601
Categoria #
all - tutte 6.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020445 0 0 0 0 0 70 89 93 79 65 14 35
2020/2021233 62 27 7 4 5 7 0 18 26 11 13 53
2021/2022406 26 6 30 17 60 27 5 22 24 23 78 88
2022/2023581 58 90 27 76 47 41 23 31 112 14 26 36
2023/2024106 7 21 11 3 6 6 11 17 3 11 3 7
2024/2025322 31 96 36 40 119 0 0 0 0 0 0 0
Totale 2.601